Allelica, Inc’s Post

Dive deep into your genetics - The future of diagnostics is molecular. In a world that is constantly evolving, so too is the field of diagnostics. At” Lab Science Diagnostics”, we are committed to staying at the forefront of this evolution. We are excited to announce our cutting-edge Molecular Diagnostic Services, specially designed to provide precise and timely results, helping you to make informed health decisions. Molecular diagnostics is the future of personalized medicine. This form of testing uses innovative technologies to analyze biological markers in the genome and proteome. Our Molecular Diagnostic Services offer a wide array of tests that provide detailed insights into your health at a molecular level. These tests can help detect diseases earlier, determine genetic predisposition to certain conditions, and guide effective treatment strategies. For more information about our Molecular Diagnostic Services or to schedule a consultation, please contact our dedicated team at 𝟬𝟵𝟲𝟯𝟴-𝟮𝟮𝟰𝟰𝟬𝟬. Take the first step towards personalized health care today. #moleculardiagnostics #moleculartest #diagnostics #labsciencediagnostics #labsciencebd

Phenomics, the comprehensive study of phenotypes on a genomic scale, promises to transform how we approach medical treatments and disease prevention. By analyzing the vast array of phenotypic data—such as physical traits, behaviors, and biochemical markers—we can gain deeper insights into how genetic variations manifest in individuals. Dr. Hood explains that this approach will enable more personalized and precise medical interventions. Watch this video for full details: https://buff.ly/3KjZLwe #PrecisionMedicine #Phenomics #HealthcareInnovation #FutureOfMedicine #UKHealthCare

Complex multimodal datasets require tools that can capture their full value. Principal Research Scientist Andrew McDavid, PhD, shares how using Ozette Discovery™ uncovered deeper insights from a previously published COVID-19 CITE-seq dataset. Ozette published new research exploring how Ozette Discovery™ can leverage the multimodal protein and RNA signal from #CITEseq data to identify predictors of disease severity. Download the preprint to learn how Ozette Discovery™ delivers computationally-derived insights at unmatched speed and resolution: https://loom.ly/-1DTG4g

Understanding cellular senescence is crucial for unraveling the genetic complexities associated with aging and disease. A network-community analysis approach utilizing network-based methodologies revealed genetic markers linked to cellular senescence and potential molecular targets. This method showcases a promising strategy for studying complex cellular phenotypes, offering valuable insights into the underlying mechanisms of senescence. #CellularSenescence #GeneticComplexity #Bioinformatics #SenescenceMarkers #CellularAging Read more here: https://lnkd.in/e3Yfv7_F BioMedHack.com is your leading source for the latest news, breakthroughs, and insights in medicine, biohacking, and alternative medicine. Our mission is to help you live healthier and longer by bringing you cutting-edge information and expert advice. Follow us on Facebook, Instagram, and X.

We’re excited to support #MicrobiomeForum as silver sponsors! Meet our team at BaseClear’s stand to discuss your microbiome projects and don’t miss Eline S. Klaassens, Human Health Product Manager's presentation on "Using omics techniques to analyze the microbiome in clinical samples" on Day 1 14.25-14.40. The application of #omics techniques in analyzing the #microbiome within #clinicaltrials has revolutionized biomedical research. #Genomics, #transcriptomics, and #metabolomics offer a comprehensive understanding of microbial communities and their roles in health and disease. Eline’s presentation will delve into recent advancements in omics technologies, showcasing how microbiome data enhances our understanding of the microbiome-host interplay, informing clinical decisions and advancing our knowledge of host-microbiome interactions. Derek Butler Radhika Bongoni, PhD MBA Dominika Viola-Durechova, PhD

Reshaping Canada’s Healthcare Crisis with Technology, Genomics, and AI - part 2 Genomics: Personalized Medicine for a Diverse Population Canada's diverse population presents unique healthcare challenges, but genomics research offers a path to personalized medicine. Genomics allows for a deeper understanding of how genetic makeup influences disease susceptibility and treatment responses. For example: Cancer treatment: Advances in genomics enable targeted therapies tailored to an individual’s genetic profile, improving outcomes while minimizing side effects. Rare diseases: Genomic sequencing can help diagnose conditions that might otherwise remain unidentified for years, providing earlier interventions and saving costs. Preventative care: By identifying genetic predispositions, genomics can guide lifestyle and medical recommendations to prevent chronic diseases like diabetes and cardiovascular disease. Gerontology: Canada is an aging population. There are 7.3 million seniors. Almost 20% of the population. The impact of our aging population on the healthcare system is only beginning to be understood. A sizable amount of all healthcare budgets will have to be allocated to geriatric care. Changes in gene expression due to epigenetic modifications, such as DNA methylation, are associated with aging. Genomic research helps map these changes, contributing to the development of biomarkers for biological age. Studies such as the sex-change studies that have taken place at Osaka University have challenged DNA methylation, and may be profoundly impactful in gerontology. Genomics helps uncover the genetic and molecular mechanisms behind cellular senescence, a process where cells lose their ability to divide and function. Senescence contributes to tissue damage, chronic inflammation, and aging-related diseases. By identifying genes involved in senescence, researchers can develop interventions, such as senolytics (drugs that remove senescent cells), to mitigate aging-related damage. With more seniors ageing healthfully, the strain of an ageing population on the healthcare system will be mitigated. Canada’s leadership in initiatives like Genome Canada ( https://genomecanada.ca/) positions the country to leverage these advancements effectively. However, integrating genomics into routine healthcare requires investment in infrastructure, training, and equitable access to ensure benefits reach all Canadians. #CanadaHealthcareCrisis, #Telehealth #GenomicsResearch, #Genomics #Gerontology, #AIinHealthcare, #PersonalizedMedicine, #DigitalHealthTechnologies, #FutureofMedicine, #EquityinHealthcare

A new research paper by our incredible teams at Google Research and Google DeepMind shows the strong performance of Med-Gemini across a variety of multimodal tasks, including  2D and 3D imaging in radiology, histopathology, ophthalmology, and dermatology, and genomics. Med-Gemini ranked best in class on chest X-ray and CT scan report generation, and is able to perform genomics-based disease prediction and mortality risk more accurately than a standard linear polygenic risk score (PRS) based approach. This work couldn't have been possible without close collaboration with our partners, including a panel of specialists who assessed and rated our models as part of this research. These promising results showcase the potential of LLMs to transform medicine as we know it. https://lnkd.in/dHx8_DYh

Rowan Gardner will present our groundbreaking work to understand the disease biology of #MECFS at the 16th International InvestinME Research Conference today. #IIMEC16 takes place today at the Wellcome Genome Campus with a focus on Advancing Understanding of ME: Bridging Research and Clinical Treatment. Rowan will share how the PrecisionLife #CausalAI platform has identified: 🧬 Genetic mechanisms causing #ME and #longCovid. ⚕️ Actively protective biology that may prevent people from getting ME and help people living with ME to recover. 💊 Precision medicine and drug repurposing candidates to treat patients which we are now validating in clinical trials with Metrodora Institute. This research is made possible by the support of patients who offer their data for analysis to benefit the wider community, and our ME/CFS and long Covid partners, including Action for M.E., DecodeME, Sano Genetics and Metrodora Foundation. Visit the #IIMEC16 event website ➡️ https://lnkd.in/eFy_j-S8 Read more about our research into ME/CFS and long Covid ➡️ https://lnkd.in/eK_DsRQ8

To mark the 50th anniversary of Cell Press, Dr. Xu Xun, Director of #BGI-Research, along with a team from BGI-Research, was invited to contribute a scientific review. They focused on the technical development and challenges of spatiotemporal omics and its potential to enhance our understanding of the human genome. This review was published today in the special issue "Leading Edge" in Cell. https://lnkd.in/dGMgwrgu